Patient characteristics
| Patient no. . | Age, y . | Sex . | FAB . | Karyotype . | WBC, ×109/L . | PB blast, % . | BM blast, . | FLT3/ITD . |
|---|---|---|---|---|---|---|---|---|
| 1 | 38 | M | M1 | 46, XY | 67.0 | 92.5 | 85.6 | − |
| 2 | 35 | M | M1 | 46, XY | 4.9 | 22 | 76 | − |
| 3 | 34 | M | M2 | 46, XY | 3.7 | 9 | 38.4 | − |
| 4 | 27 | M | M2 | 46, XY | 25.8 | 82.7 | 67.3 | − |
| 5 | 57 | M | M2 | 46, XY, del(20)(q11;q13) | 2.2 | 1 | 21.6 | − |
| 6 | 57 | M | M2 | 46, XY, +8 | 2.0 | 0 | 49.8 | − |
| 7 | 84 | M | M2 | 45, XY, −7 | 3.8 | 41 | 64.8 | − |
| 8 | 32 | M | M2 | 45, X, −Y, t(8;21)(q22;q22) | 29.4 | 73.8 | 56.8 | − |
| 9 | 19 | M | M2 | 46, XY, t(8;21)(q22;q22) | 2.3 | 11 | 21.3 | − |
| 10 | 30 | F | M2 | 45, X, −X, t(8;21)(q22;q22) | 16.5 | 65 | 79.9 | − |
| 11 | 46 | M | M2 | 46, XY, t(8;21)(q22;q22) | 14.3 | 56 | 82.2 | − |
| 12 | 62 | F | M3 | 46, XX, t(15;17)(q22;q21), add(18)(p11.2), add(20)(q13) | 52.5 | 97 | 96 | − |
| 13 | 33 | F | M3 | 46, XX, t(15;17)(q22;q21) | 65.1 | 78 | 87.5 | − |
| 14 | 24 | F | M3 | 46, XX, t(15;17)(q22;q21) | 2.3 | 24 | 65 | − |
| 15 | 50 | F | M4 | 46, XX | 43.7 | 17 | 31.6 | − |
| 16 | 75 | M | M4 | 46, XY | 18.3 | 3 | 70 | − |
| 17 | 58 | F | M5 | 46, XX, t(3;3)(q21;q26) | 11.3 | 53 | 60 | − |
| 18 | 48 | F | M5 | 49, XX, +8, t(9;11)(p22;q23), +14 | 1.6 | 23 | 90 | − |
| 19 | 71 | M | M6 | NA | 4.5 | 1 | 28 | − |
| 20 | 86 | M | M0 | 46, XY | 17.3 | 63 | 92 | + |
| 21 | 84 | F | M1 | 48, XX, +8 | 8.5 | 94 | 98 | + |
| 22 | 33 | F | M1 | 46, XX | 135.7 | 98 | 99.2 | + |
| 23 | 52 | F | M1 | 46, XX | 171.6 | 97 | 90 | + |
| 24 | 19 | F | M2 | 46, XY, t(8;21)(q22;q22) | 12.3 | 45 | 86 | + |
| 25 | 59 | M | M3 | 46, XY, t(15;17)(q22;q21) | 3.8 | 51 | 77.2 | + |
| 26 | 56 | M | M3 | 46, XY, t(15;17)(q22;q21) | 4.4 | 83 | 92.5 | + |
| 27 | 48 | F | M4 | 46, XX | 31.5 | 77.5 | 36 | + |
| 28 | 29 | M | M4 | 46, XY | 155.0 | 68.8 | 73 | + |
| 29 | 19 | M | M4 | 46, XY | 144.0 | 83.5 | 35 | + |
| 30 | 20 | M | M7 | 46, XY | 48.3 | 92 | 99 | + |
| Patient no. . | Age, y . | Sex . | FAB . | Karyotype . | WBC, ×109/L . | PB blast, % . | BM blast, . | FLT3/ITD . |
|---|---|---|---|---|---|---|---|---|
| 1 | 38 | M | M1 | 46, XY | 67.0 | 92.5 | 85.6 | − |
| 2 | 35 | M | M1 | 46, XY | 4.9 | 22 | 76 | − |
| 3 | 34 | M | M2 | 46, XY | 3.7 | 9 | 38.4 | − |
| 4 | 27 | M | M2 | 46, XY | 25.8 | 82.7 | 67.3 | − |
| 5 | 57 | M | M2 | 46, XY, del(20)(q11;q13) | 2.2 | 1 | 21.6 | − |
| 6 | 57 | M | M2 | 46, XY, +8 | 2.0 | 0 | 49.8 | − |
| 7 | 84 | M | M2 | 45, XY, −7 | 3.8 | 41 | 64.8 | − |
| 8 | 32 | M | M2 | 45, X, −Y, t(8;21)(q22;q22) | 29.4 | 73.8 | 56.8 | − |
| 9 | 19 | M | M2 | 46, XY, t(8;21)(q22;q22) | 2.3 | 11 | 21.3 | − |
| 10 | 30 | F | M2 | 45, X, −X, t(8;21)(q22;q22) | 16.5 | 65 | 79.9 | − |
| 11 | 46 | M | M2 | 46, XY, t(8;21)(q22;q22) | 14.3 | 56 | 82.2 | − |
| 12 | 62 | F | M3 | 46, XX, t(15;17)(q22;q21), add(18)(p11.2), add(20)(q13) | 52.5 | 97 | 96 | − |
| 13 | 33 | F | M3 | 46, XX, t(15;17)(q22;q21) | 65.1 | 78 | 87.5 | − |
| 14 | 24 | F | M3 | 46, XX, t(15;17)(q22;q21) | 2.3 | 24 | 65 | − |
| 15 | 50 | F | M4 | 46, XX | 43.7 | 17 | 31.6 | − |
| 16 | 75 | M | M4 | 46, XY | 18.3 | 3 | 70 | − |
| 17 | 58 | F | M5 | 46, XX, t(3;3)(q21;q26) | 11.3 | 53 | 60 | − |
| 18 | 48 | F | M5 | 49, XX, +8, t(9;11)(p22;q23), +14 | 1.6 | 23 | 90 | − |
| 19 | 71 | M | M6 | NA | 4.5 | 1 | 28 | − |
| 20 | 86 | M | M0 | 46, XY | 17.3 | 63 | 92 | + |
| 21 | 84 | F | M1 | 48, XX, +8 | 8.5 | 94 | 98 | + |
| 22 | 33 | F | M1 | 46, XX | 135.7 | 98 | 99.2 | + |
| 23 | 52 | F | M1 | 46, XX | 171.6 | 97 | 90 | + |
| 24 | 19 | F | M2 | 46, XY, t(8;21)(q22;q22) | 12.3 | 45 | 86 | + |
| 25 | 59 | M | M3 | 46, XY, t(15;17)(q22;q21) | 3.8 | 51 | 77.2 | + |
| 26 | 56 | M | M3 | 46, XY, t(15;17)(q22;q21) | 4.4 | 83 | 92.5 | + |
| 27 | 48 | F | M4 | 46, XX | 31.5 | 77.5 | 36 | + |
| 28 | 29 | M | M4 | 46, XY | 155.0 | 68.8 | 73 | + |
| 29 | 19 | M | M4 | 46, XY | 144.0 | 83.5 | 35 | + |
| 30 | 20 | M | M7 | 46, XY | 48.3 | 92 | 99 | + |
PB indicates peripheral blood; BM, bone marrow; M, male; and F, female.